-+ 0.00%
-+ 0.00%
-+ 0.00%
Ausnutria Dairy (SEHK:1717) Stock Faces Deeper Losses As Revenue Slides
Share
Listen to the news

Ausnutria Dairy stock closed at HK$1.20 today, barely moved over the past week, yet the earnings story feels anything but flat. The market is still treating the company as a lowly valued turnaround idea, but the latest half year results show a much heavier profit squeeze than that label suggests.

Revenue in H1 2026 came in at ¥3,163.18m, yet the company reported a net loss of ¥705.05m and a basic loss per share of ¥0.3969. For a dairy producer that investors often assess on cash generation and margin stability, that scale of loss is the headline to focus on before looking at any forecast recovery.

Like the Ausnutria Dairy brand but worried by the recent net loss and earnings pressure? Benchmark this setup against our list of solid balance sheet and fundamentals stocks (426 results).

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): ¥3,163.18m vs. ¥3,886.79m (Revenue declined year on year)
  • Net Loss, excl. extra items (H1 2026 vs. H1 2025): ¥705.05m loss vs. ¥180.45m profit (Moved from profit to a materially larger loss)
  • Basic EPS (H1 2026 vs. H1 2025): ¥0.3969 loss per share vs. ¥0.1014 earnings per share (Shifted from earnings to a wider per share loss)
  • Trailing twelve month Net Loss, excl. extra items (TTM to H1 2026 vs. TTM to H1 2025): ¥708.00m loss vs. ¥271.04m profit (Moved from profit over the prior year to a substantial trailing loss)

Prefer clear visuals over another wall of figures and earnings jargon? See Ausnutria Dairy’s full financial picture, including how its recent loss flows through the balance sheet and broader fundamentals, in the company report for Ausnutria Dairy.

SEHK:1717 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SEHK:1717 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Ausnutria Dairy bullish story meets profit reality

For anyone leaning bullish on Ausnutria Dairy as a health and nutrition platform, the latest figures create a tension with that view. Revenue in H1 2026 of ¥3,163.18m gives the company scale across its dairy and nutrition segments, which still matters for brand reach and shelf presence. However, the move from a ¥180.45m profit in H1 2025 to a ¥705.05m loss, and a trailing loss of ¥708.00m, puts profitability under clear pressure, so any positive long term product story now sits behind a much tougher earnings backdrop.

Bearish concerns strengthened by deeper earnings setback

Bearish investors worried about Ausnutria Dairy’s earnings resilience and balance sheet pressure will see these results as supportive of that caution. The swing from earnings per share of ¥0.1014 in H1 2025 to a loss per share of ¥0.3969, together with the move from a trailing profit of ¥271.04m to a trailing loss of ¥708.00m, signals a broad deterioration in recent profitability. With the share price flat over the past week at HK$1.20, the market reaction so far looks muted, yet the financial trend points to elevated execution and margin risk right now.

Compare Ausnutria Dairy’s earnings reset with where institutional expectations sit. See the consensus price target analysis for Ausnutria Dairy to check how current analyst targets compare with this turnaround story.

Stay Ahead Of Your Next Move

If Ausnutria Dairy’s recent swing from profit to loss has your attention, register for free with Simply Wall St and add the stock to your Watchlist to track its price alongside fair value estimates and watch for a setup that fits your plan. After you commit capital, keep your holdings organised with the Portfolio Command Center so you only see focused, high impact updates instead of day to day noise. For a longer term view, use the Community to tap into a broad range of investor opinions and questions around Ausnutria Dairy and similar stocks. This way you can surface potential catalysts and risks earlier and stay a step ahead of the wider market.

Seeking Alternatives Beyond Ausnutria Dairy?

Fresh stock ideas can move from quiet to breakout before most investors notice. Use these screeners while the momentum is under the radar for now and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending